Hologic: Martin Madaus

Hologic has appointed Martin Madaus to a newly created position on the company's board of directors effective Dec. 6. The firm said in a filing with the US Securities and Exchange Commission that Madaus was appointed to the board when it was expanded from nine members to 10. He was also appointed to Hologic's compensation committee and its nominating and corporate governance committee. Madaus is an operating executive for the Carlyle Group, and he previously served as the chairman and CEO of Ortho Clinical Diagnostics. He had also was chairman, president, and CEO of life sciences firm Millipore prior to its 2010 acquisition by Merck.